Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.ijantimicag.2013.09.011
DC FieldValue
dc.titleThe emergence of community-onset Clostridium difficile infection in a tertiary hospital in Singapore: A cause for concern
dc.contributor.authorTan, X.Q.
dc.contributor.authorVerrall, A.J.
dc.contributor.authorJureen, R.
dc.contributor.authorRiley, T.V.
dc.contributor.authorCollins, D.A.
dc.contributor.authorLin, R.T.
dc.contributor.authorBalm, M.N.
dc.contributor.authorChan, D.
dc.contributor.authorTambyah, P.A.
dc.date.accessioned2016-07-08T09:27:46Z
dc.date.available2016-07-08T09:27:46Z
dc.date.issued2014-01
dc.identifier.citationTan, X.Q., Verrall, A.J., Jureen, R., Riley, T.V., Collins, D.A., Lin, R.T., Balm, M.N., Chan, D., Tambyah, P.A. (2014-01). The emergence of community-onset Clostridium difficile infection in a tertiary hospital in Singapore: A cause for concern. International Journal of Antimicrobial Agents 43 (1) : 47-51. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ijantimicag.2013.09.011
dc.identifier.issn09248579
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/125488
dc.description.abstractIncreasing rates of Clostridium difficile infection (CDI) among those without traditional risk factors have been reported mainly in Europe and North America. Here we describe the epidemiology, clinical features and ribotypes of CDI at National University Hospital (NUH), a 1000-bed tertiary care hospital in Singapore, from December 2011 to May 2012. All laboratory-confirmed CDI cases ≥21 years old who gave informed consent were included. Clinical data were collected prospectively and participants underwent an interviewer-administered questionnaire. Cases were classified by healthcare facility exposure and severity according to the SHEA guidelines. Included cases were also subjected to PCR and were classified by ribotype. In total, 66 patients participated in the study, of which 33 (50.0%) were healthcare-facility-associated hospital onset (HCFA-HO). Of the 33 community-onset (CO) cases, 14 (42.4%) were HCFA-CO, 10 (30.3%) were indeterminate and 9 (27.3%) were community-associated (CA). Of the CA cases, a majority (90.9%) had prior exposure to a healthcare facility within the last 12 weeks. Clinical characteristics, exposures and outcomes were not different between HO-CDI and CO-CDI. Diagnosis was delayed in CO-CDI compared with HO-CDI (4 days vs. 1 day; P = 0.014). There was no difference in distribution of ribotypes between CO-CDI and HO-CDI, with 053 being most prevalent in both groups. CO-CDI increasingly contributes to the burden of CDI in NUH. This may reflect a trend in other parts of Asia. Healthcare professionals should be aware of the possible role of outpatient healthcare environments to CDI risk and thus extend control measures to outpatient settings. © 2013 Elsevier B.V. and the International Society of Chemotherapy.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.ijantimicag.2013.09.011
dc.sourceScopus
dc.subjectClostridium difficile
dc.subjectInfection control
dc.subjectRibotyping
dc.typeArticle
dc.contributor.departmentMEDICINE
dc.contributor.departmentPATHOLOGY
dc.description.doi10.1016/j.ijantimicag.2013.09.011
dc.description.sourcetitleInternational Journal of Antimicrobial Agents
dc.description.volume43
dc.description.issue1
dc.description.page47-51
dc.description.codenIAAGE
dc.identifier.isiut000329063500007
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.